AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...

Phase IIb study on ANAB's ANB032 for atopic dermatitis fails to meet goals. The company decides to discontinue any further investment in the candidate.

ANB032 was well tolerated across all doses with no safety signals observed; AD trial and all further investment in ANB032 will be discontinued; Anticipate top-line Phase 2b data i ...

Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...

December 12, 2024 • In 2012, Karam Shaar had to leave his home country of Syria due to the civil war. But he still wanted to make a difference. Through his economic analysis, he uncovered ...

Canada Post, union still at odds as strike nears 1 month Canada Post, union still at odds as strike nears 1 month Canada Post says the latest offer from the union representing its striking workers ...

European Space Agency launches Proba-3 to create an artificial solar eclipse and study the sun’s atmosphere, the corona.

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

US Bankers Are Cautious Towards Cryptos Despite Upcoming Pro-Crypto Administration ...

As 2024 comes to an end, Google looks back at the top trending searches of the year and reveals the most popular topics and persons Greeks hunted for -from sports, where UEFA's European Football ...